Showing results (381-390 of 458) with videos related to

Sort By:
Pageof 46
Gynecologic Oncology|January 13, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Risk-Based Colposcopy PracticeNicolas Wentzensen, Mark Schiffman, Michelle I Silver, et al.
Obstetrics and Gynecology|January 9, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Plos One|October 18, 2021
Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city-Lessons learned from the Amazon city of Manaus, BrazilKátia Luz Torres, Heidy Halanna de Melo Farah Rondon, Toni Ricardo Martins, et al.
The Journal of Infectious Diseases|December 16, 2020
Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine TrialMónica S Sierra, Sabrina H Tsang, Shangying Hu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2004
Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa RicaSophia S Wang, Marcus Trunk, Mark Schiffman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive womenJulia C Gage, Ana Cecilia Rodriguez, Mark Schiffman, et al.
International Journal of Cancer|September 29, 2023
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional studyFederica Inturrisi, Silvia de Sanjosé, Kanan T Desai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 6, 2013
Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine TrialMahboobeh Safaeian, Carolina Porras, Yuanji Pan, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic PracticeMichelle J Khan, Claudia L Werner, Teresa M Darragh, et al.
Pageof 46